Related Experiment Video
Updated: Jun 17, 2026

10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
24.8K
Transcriptomes from German shepherd dogs reveal differences in immune activity between atopic dermatitis affected and
K Tengvall1, K Bergvall2, M Olsson3
1Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden. Katarina.Tengvall@imbim.uu.se.
Immunogenetics
|June 20, 2020
Summary
This study identified seven key genes in German shepherd dogs with canine atopic dermatitis (CAD), offering insights into the skin
Area of Science:
- Veterinary Dermatology
- Molecular Biology
- Immunology
Background:
- Canine atopic dermatitis (CAD) is a common allergic skin disease in dogs.
- Genetic and environmental factors contribute to CAD pathogenesis.
- Understanding the molecular basis of CAD is crucial for effective treatment.
Purpose of the Study:
- To identify differentially expressed genes (DEGs) in the skin of dogs with CAD.
- To investigate the role of specific genes in CAD development and progression.
- To provide a molecular basis for understanding post-treatment atopic skin.
Main Methods:
- mRNA sequencing of non-lesional axillary skin biopsies from German shepherd dogs.
- Mapping RNA sequences to the dog genome (CanFam3.1).
- Differential gene expression analysis comparing control and CAD cases using leave-one-out analysis.
Main Results:
- A high-quality skin transcriptome with 23,510 expressed gene transcripts was generated.
- Seven differentially expressed genes (DEGs) were identified in CAD cases.
- DEGs include immune-related genes, an odorant-binding protein, and a novel long non-coding RNA.
Conclusions:
- The identified DEGs provide insights into the molecular mechanisms underlying canine atopic dermatitis.
- Specific genes may play a role in immune activation and rhinitis associated with CAD.
- Further research with larger sample sizes is needed to validate findings for clinical application.

